T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
- PMID: 7732003
- PMCID: PMC42068
- DOI: 10.1073/pnas.92.9.3893
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
Abstract
Atherosclerosis, an underlying cause of myocardial infarction, stroke, and other cardiovascular diseases, consists of focal plaques characterized by cholesterol deposition, fibrosis, and inflammation. The presence of activated T lymphocytes and macrophages and high expression of HLA class II molecules are indicative of a local immunologic activation in the atherosclerotic plaque, but the antigen(s) involved has not yet been identified. We established T-cell clones from human atherosclerotic plaques using polyclonal mitogens as stimuli and exposed the clones to potential antigens in the presence of autologous monocytes as antigen-presenting cells. Four of the 27 CD4+ clones responded to oxidized low density lipoprotein (oxLDL) by proliferation and cytokine secretion; this response was dependent on autologous antigen-presenting cells and restricted by HLA-DR. All clones that responded to oxLDL secreted interferon gamma upon activation, but only one produced interleukin 4, suggesting that the response to oxLDL results in immune activation and inflammation but may not be a strong stimulus to antibody production. No significant response to oxLDL could be detected in CD4+ T-cell clones derived from the peripheral blood of the same individuals. Together, the present data suggest that the inflammatory infiltrate in the atherosclerotic plaque is involved in a T-cell-dependent, autoimmune response to oxLDL.
Similar articles
-
Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation.Atherosclerosis. 2001 May;156(1):11-21. doi: 10.1016/s0021-9150(00)00575-x. Atherosclerosis. 2001. PMID: 11368992
-
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.Circ Res. 2005 Mar 4;96(4):427-34. doi: 10.1161/01.RES.0000156889.22364.f1. Epub 2005 Jan 20. Circ Res. 2005. PMID: 15662027
-
Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques.J Pathol. 1999 Jun;188(2):174-9. doi: 10.1002/(SICI)1096-9896(199906)188:2<174::AID-PATH333>3.0.CO;2-3. J Pathol. 1999. PMID: 10398161
-
Clonal sketches of the immune response.EMBO J. 1988 Oct;7(10):2945-51. doi: 10.1002/j.1460-2075.1988.tb03156.x. EMBO J. 1988. PMID: 3053159 Free PMC article. Review. No abstract available.
-
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside.Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):194-9. doi: 10.1093/ehjcvp/pvw001. Epub 2016 Jan 24. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27418972 Free PMC article. Review.
Cited by
-
TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice.PLoS One. 2012;7(3):e33932. doi: 10.1371/journal.pone.0033932. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479479 Free PMC article.
-
ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis.Cells. 2021 Feb 19;10(2):446. doi: 10.3390/cells10020446. Cells. 2021. PMID: 33669769 Free PMC article. Review.
-
Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis.Cells. 2021 Mar 24;10(4):723. doi: 10.3390/cells10040723. Cells. 2021. PMID: 33805071 Free PMC article. Review.
-
Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models.J Am Heart Assoc. 2012 Feb;1(1):27-41. doi: 10.1161/JAHA.111.000125. Epub 2012 Feb 20. J Am Heart Assoc. 2012. PMID: 23130116 Free PMC article.
-
The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.Antioxid Redox Signal. 2014 Jan 1;20(1):102-20. doi: 10.1089/ars.2013.5258. Epub 2013 Apr 19. Antioxid Redox Signal. 2014. PMID: 23472597 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials